An Overview of Biomarkers and Molecular Signatures in HCC
AbstractHepatocellular carcinoma (HCC) is the third most common cause of cancer mortality worldwide. Although most HCCs seem to originate from the accumulation of genetic abnormalities induced by various risk factors, underlying mechanisms of hepatocarcinogenesis remain unclear. Long-term survival of HCC patients is also poor, partly due to HCC recurrence. Although serum alpha-fetoprotein (AFP) level is a useful marker for the detection and monitoring of HCC, AFP levels may remain normal in the patients even with advanced HCC. To identify useful biomarkers for HCC, many studies have been conducted on molecular events such as genetic and epigenetic alterations, and gene expression. This review summarizes recent studies of potential molecular markers for diagnosis and monitoring metastasis or recurrence of HCC.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Yim, S.-H.; Chung, Y.-J. An Overview of Biomarkers and Molecular Signatures in HCC. Cancers 2010, 2, 809-823.
Yim S-H, Chung Y-J. An Overview of Biomarkers and Molecular Signatures in HCC. Cancers. 2010; 2(2):809-823.Chicago/Turabian Style
Yim, Seon-Hee; Chung, Yeun-Jun. 2010. "An Overview of Biomarkers and Molecular Signatures in HCC." Cancers 2, no. 2: 809-823.